Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-024253
Filing Date
2025-11-19
Accepted
2025-11-19 16:06:19
Documents
81
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1188132
2 EX-31.1 ex31-1.htm EX-31.1 16833
3 EX-31.2 ex31-2.htm EX-31.2 16663
4 EX-32.1 ex32-1.htm EX-32.1 6990
5 EX-32.2 ex32-2.htm EX-32.2 7048
  Complete submission text file 0001493152-25-024253.txt   6496759

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20250930.xsd EX-101.SCH 49964
7 XBRL CALCULATION FILE vvos-20250930_cal.xml EX-101.CAL 72236
8 XBRL DEFINITION FILE vvos-20250930_def.xml EX-101.DEF 200830
9 XBRL LABEL FILE vvos-20250930_lab.xml EX-101.LAB 390573
10 XBRL PRESENTATION FILE vvos-20250930_pre.xml EX-101.PRE 317101
83 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 988844
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 251499411
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)